{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:54:49Z","timestamp":1794264889235,"version":"4.9.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bpobgyn.2025.102603","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:19:38Z","timestamp":1741983578000},"page":"102603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Can we really protect the ovary from chemotherapy damage?"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7298-5168","authenticated-orcid":false,"given":"Thuy Truong An","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3192-6565","authenticated-orcid":false,"given":"Isabelle","family":"Demeestere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2025.102603_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1470-2045(23)00646-0","article-title":"Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study","volume":"25","author":"De Angelis","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/annonc\/mdg756","article-title":"EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century","volume":"14","author":"Coleman","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study","volume":"15","author":"De Angelis","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.fertnstert.2011.10.040","article-title":"Impact of cancer therapies on ovarian reserve","volume":"97","author":"Gracia","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2021.11.011","article-title":"Family size and duration of fertility in female cancer survivors: a population-based analysis","volume":"117","author":"Anderson","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/humrep\/deac249","article-title":"Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation","volume":"38","author":"Fraison","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib7","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s10815-018-1216-3","article-title":"Decreased pregnancy and live birth rates after vitrification of in vitro matured oocytes","volume":"35","author":"Cohen","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib8","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/humrep\/dev128","article-title":"Live birth after autograft of ovarian tissue cryopreserved during childhood","volume":"30","author":"Demeestere","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/toxsci\/kfj086","article-title":"Characterizing the ovotoxicity of cyclophosphamide metabolites on cultured mouse ovaries","volume":"90","author":"Desmeules","year":"2006","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nm.2033","article-title":"Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death","volume":"15","author":"Gonfloni","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070117","article-title":"Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin","volume":"8","author":"Morgan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib12","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/jog.16004","article-title":"Role of DNA damage response in cyclophosphamide-induced premature ovarian failure in mice","volume":"50","author":"Song","year":"2024","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.taap.2014.11.017","article-title":"Phosphoramide mustard exposure induces DNA adduct formation and the DNA damage repair response in rat ovarian granulosa cells","volume":"282","author":"Ganesan","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009204","article-title":"Enhancing survival of mouse oocytes following chemotherapy or aging by targeting Bax and Rad51","volume":"5","author":"Kujjo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0633-7","article-title":"Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility","volume":"9","author":"Nguyen","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib16","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/humupd\/dms022","article-title":"How do chemotherapeutic agents damage the ovary?","volume":"18","author":"Morgan","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41419-024-07202-7","article-title":"Oocyte death is triggered by the stabilization of TAp63\u03b1 dimers in response to cisplatin","volume":"15","author":"Abazarikia","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg0898","article-title":"CHEK2 signaling is the key regulator of oocyte survival after chemotherapy","volume":"9","author":"Emori","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1371\/journal.pone.0023492","article-title":"In vivo bioimaging as a novel strategy to detect Doxorubicin-Induced damage to gonadal blood vessels","volume":"6","author":"Bar-Joseph","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005402","article-title":"Cyclophosphamide triggers follicle activation and \"Burnout \"; AS101 prevents follicle loss and preserves fertility","volume":"5","author":"Kalich-Philosoph","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib21","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.fertnstert.2020.11.040","article-title":"Ovaries of patients recently treated with alkylating agent chemotherapy indicate the presence of acute follicle activation , elucidating its role among other proposed mechanisms of follicle loss","volume":"115","author":"Shai","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.rbmo.2016.10.005","article-title":"Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro","volume":"34","author":"Lande","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib23","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/humrep\/dead064","article-title":"Dual suppression of follicle activation pathways completely prevents the cyclophosphamide-induced loss of ovarian reserve","volume":"38","author":"Kashi","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib24","doi-asserted-by":"crossref","first-page":"13885","DOI":"10.1096\/fj.202001461RR","article-title":"Continuous treatment with cisplatin induces the oocyte death of primordial follicles without activation","volume":"34","author":"Eldani","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib25","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/376785a0","article-title":"Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents","volume":"376","author":"Kharbanda","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/cdd.2010.132","article-title":"C-Abl tyrosine kinase in the DNA damage response: cell death and more","volume":"18","author":"Meltser","year":"2011","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib27","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2889","article-title":"Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib","volume":"18","author":"Kerr","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib28","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nm.2852","article-title":"Reply to: cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib","volume":"18","author":"Maiani","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib29","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/cdd.2013.31","article-title":"Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network","volume":"20","author":"Kim","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/s41419-018-1026-7","article-title":"C-Abl is not act\u0131vated in DNA damage-induced and Tap63-mediated oocyte apoptos\u0131s in human ovary","volume":"9","author":"Bildik","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.5653\/cerm.2022.05218","article-title":"Impact of imatinib administration on the mouse ovarian follicle count and levels of intra-ovarian proteins related to follicular quality","volume":"49","author":"Kim","year":"2022","journal-title":"Clinical and Experimental Reproductive Medicine"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib32","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10815-020-01778-7","article-title":"Long-term imatinib diminishes ovarian reserve and impacts embryo quality","volume":"37","author":"Salem","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib33","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/ijms22031395","article-title":"Asciminib mitigates DNA damage stress signaling induced by cyclophosphamide in the ovary","volume":"22","author":"Mattiello","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5653\/cerm.2020.03755","article-title":"Impact of imatinib or dasatinib coadministration on in vitro preantral follicle development and oocyte acquisition in cyclophosphamide-treated mice","volume":"47","author":"Hong","year":"2020","journal-title":"Clinical and Experimental Reproductive Medicine"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib35","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41419-019-1961-y","article-title":"Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility","volume":"10","author":"Bellusci","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib36","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41418-018-0151-2","article-title":"Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies","volume":"26","author":"Kim","year":"2019","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41594-018-0035-7","article-title":"Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63","volume":"25","author":"Tuppi","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/JOE-18-0370","article-title":"Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide","volume":"240","author":"Luan","year":"2019","journal-title":"J Endocrinol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib39","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.fertnstert.2006.06.020","article-title":"Sphingosine 1-phosphate protects ovaries from chemotherapy-induced damage in vivo","volume":"87","author":"Hancke","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humrep\/det391","article-title":"Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death","volume":"29","author":"Li","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejogrb.2018.01.001","article-title":"Sphingosine-1-phosphate protects human ovarian follicles from apoptosis in vitro","volume":"222","author":"Guzel","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.fertnstert.2014.05.040","article-title":"Sphingosine-1-phosphate suppresses cyclophosphamide induced follicle apoptosis in human fetal ovarian xenografts in nude mice","volume":"102","author":"Meng","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib43","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/humrep\/dey045","article-title":"Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure","volume":"33","author":"Pascuali","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib44","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.fertnstert.2007.03.065","article-title":"Does sphingosine-1-phosphate have a protective effect on cyclophosphamide- and irradiation-induced ovarian damage in the rat model?","volume":"89","author":"Kaya","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib45","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1177\/1933719117741376","article-title":"The impact of a long-acting oral sphingosine-1-phosphate analogue on ovarian aging in a rat model","volume":"25","author":"Mumusoglu","year":"2018","journal-title":"Reprod Sci"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib46","first-page":"14703","article-title":"SIRT1 facilitates primordial follicle recruitment independent of deacetylase activity through directly modulating Akt1 and mTOR transcription","volume":"33","author":"Zhang","year":"2019","journal-title":"FASEB (Fed Am Soc Exp Biol) J"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib47","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10815-022-02437-9","article-title":"Protective effects of a SIRT1 inhibitor on primordial follicle activation and growth induced by cyclophosphamide : insights from a bovine in vitro folliculogenesis system","volume":"39","author":"Di Emidio","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2024.104324","article-title":"Atorvastatin improves ovarian function and follicular reserve in rats with premature ovarian insufficiency","volume":"49","author":"Notghi","year":"2024","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib49","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1017\/S0967199424000315","article-title":"Resveratrol attenuates doxorubicin-induced toxicity during in vitro culture of mouse-isolated preantral follicles","volume":"32","author":"Silva","year":"2024","journal-title":"Zygote"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2024.108661","article-title":"Gentisic acid attenuates 5-fluorouracil-induced ovotoxicity in rats via modulating Nrf2 signalling: an experimental approach","volume":"128","author":"Mentese","year":"2024","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib51","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/cdd.2016.97","article-title":"LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse","volume":"24","author":"Rossi","year":"2017","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib52","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1093\/humrep\/deab165","article-title":"The cyto-protective effects of LH on ovarian reserve and female fertility during exposure to gonadotoxic alkylating agents in an adult mouse model","volume":"36","author":"Del Castillo","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib53","first-page":"3141","article-title":"Luteinizing hormone compromises the in vivo anti-tumor effect of cisplatin on human epithelial ovarian cancer cells","volume":"15","author":"Huang","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib54","article-title":"The natural carotenoid crocetin and the synthetic tellurium compound AS101 protect the ovary against cyclophosphamide by modulating SIRT1 and mitochondrial markers","author":"Di","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12958-021-00743-y","article-title":"Quercetin prevents primordial follicle loss via suppression of PI3K\/Akt\/Foxo3a pathway activation in cyclophosphamide-treated mice","volume":"19","author":"Li","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib56","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13048-022-01080-3","article-title":"Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells","volume":"15","author":"Chen","year":"2022","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/bcpt.13696","article-title":"Effects of quercetin on ovarian function and regulation of the ovarian PI3K\/Akt\/FoxO3a signalling pathway and oxidative stress in a rat model of cyclophosphamide-induced premature ovarian failure","volume":"130","author":"Zheng","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103191","article-title":"Quercetin attenuates cisplatin-induced ovarian toxicity in rats: emphasis on anti-oxidant, anti-inflammatory and anti-apoptotic activities","volume":"14","author":"Algandaby","year":"2021","journal-title":"Arab J Chem"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib59","first-page":"1","article-title":"Safety aspects of the use of quercetin as a dietary supplement. Molecular nutrition and","volume":"62","author":"Andres","year":"2018","journal-title":"Food Res"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053810","article-title":"Pharmacological inhibition of mTORC1 prevents over- activation of the primordial follicle pool in response to elevated PI3K signaling","volume":"8","author":"Adhikari","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110491","article-title":"mTORC1 signaling in oocytes is dispensable for the survival of primordial follicles and for female fertility","volume":"9","author":"Gorre","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13048-017-0350-3","article-title":"Rapamycin prevents cyclophosphamide- induced over-activation of primordial follicle pool through PI3K\/Akt\/mTOR signaling pathway in vivo","volume":"10","author":"Zhou","year":"2017","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib63","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/mrd.23330","article-title":"Rapamycin preserves the primordial follicle pool during cisplatin treatment in vitro and in vivo","volume":"87","author":"Xie","year":"2020","journal-title":"Mol Reprod Dev"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib64","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1073\/pnas.1617233114","article-title":"mTORC1\/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy","volume":"114","author":"Goldman","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib65","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1538\/expanim.18-0042","article-title":"Protective effect of a mechanistic target of rapamycin inhibitor on an in vivo model of cisplatin-induced ovarian gonadotoxicity","volume":"67","author":"Tanaka","year":"2018","journal-title":"Exp Anim"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib66","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/humrep\/del025","article-title":"The use of metformin for women with PCOS undergoing IVF treatment","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib67","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2017.06.026","article-title":"Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline","volume":"108","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/molehr\/gaaa084","article-title":"Metformin : a novel promising option for fertility preservation during cyclophosphamide-based chemotherapy","volume":"27","author":"Huang","year":"2021","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib69","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1038\/s41598-024-51990-z","article-title":"Metformin protects ovarian granulosa cells in chemotherapy-induced premature ovarian failure mice through AMPK\/PPAR-\u03b3\/SIRT1 pathway","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib70","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13048-023-01259-2","article-title":"Does the addition of metformin to carboplatin treatment decreases ovarian reserve damage associated with carboplatin usage?","volume":"16","author":"Ayhan","year":"2023","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib71","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","article-title":"Anti-M\u00fcllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib72","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/humupd\/dmac004","article-title":"Anti-M\u00fcllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review","volume":"28","author":"Anderson","year":"2022","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib73","doi-asserted-by":"crossref","first-page":"E1688","DOI":"10.1073\/pnas.1620729114","article-title":"AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy","volume":"114","author":"Kano","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib74","first-page":"1278","article-title":"AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice","volume":"33","author":"Sonigo","year":"2018","journal-title":"FASEB (Fed Am Soc Exp Biol) J"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib75","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1007\/s10815-019-01507-9","article-title":"Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects","volume":"36","author":"Roness","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib76","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/humrep\/dead255","article-title":"Anti-Mullerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro","volume":"39","author":"Rosario","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib77","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12432","article-title":"Synergistic effect of melatonin and ghrelin in preventing cisplatin-induced ovarian damage via regulation of FOXO3a phosphorylation and binding to the p27Kip1 promoter in primordial follicles","volume":"63","author":"Jang","year":"2017","journal-title":"J Pineal Res"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib78","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.3390\/pharmaceutics14122769","article-title":"Melatonin mitigates cisplatin-induced ovarian dysfunction via altering steroidogenesis, inflammation, apoptosis, oxidative stress, and PTEN\/PI3K\/Akt\/mTOR\/AMPK signaling pathway in female rats","volume":"14","author":"Al-Shahat","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2022.895095","article-title":"Melatonin prevents primordial follicle loss by inhibiting ovarian granulosa cell apoptosis and maintaining AMH expression","volume":"13","author":"Feng","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib80","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ctrv.2018.11.006","article-title":"Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: from biological evidence to clinical application","volume":"72","author":"Lambertini","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib81","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1200\/JCO.2018.78.0858","article-title":"Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient\u2013level data","volume":"36","author":"Lambertini","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib82","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.fertnstert.2014.06.003","article-title":"Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis","volume":"102","author":"Vitek","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib83","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1200\/JCO.2015.65.8864","article-title":"No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial","volume":"34","author":"Demeestere","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102335","article-title":"Gonadotropin Releasing Hormone agonist (GnRHa) during chemotherapy and post-cancer childbirths \u2013 a Nationwide population-based cohort study of 24,922 women diagnosed with cancer in Sweden","volume":"67","author":"Rodriguez-Wallberg","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib85","first-page":"1","article-title":"ESHRE guideline: female fertility preservation","volume":"2020","author":"Anderson","year":"2020","journal-title":"Human Reproduction Open"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib86","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1200\/JCO.2006.10.3028","article-title":"Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure","volume":"25","author":"Lee","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib87","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.fertnstert.2010.12.036","article-title":"Granulocyte colony-stimulating factor in conjunction with vascular endothelial growth factor maintains primordial follicle numbers in transplanted mouse ovaries","volume":"95","author":"Skaznik-Wikiel","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib88","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.fertnstert.2013.01.135","article-title":"Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insuf fi ciency in female mice treated with alkylating chemotherapy","volume":"99","author":"Skaznik-Wikiel","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib89","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3802\/jgo.2014.25.4.328","article-title":"Granulocyte-colony stimulating factor decreases the extent of ovarian damage caused by cisplatin in an experimental rat model","volume":"25","author":"Akdemir","year":"2014","journal-title":"Journal of Gynecologic Oncology"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib90","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10815-010-9463-y","article-title":"Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat","volume":"27","author":"Ting","year":"2010","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib91","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/en.2013-1214","article-title":"Insights into the protective mechanisms of tamoxifen in radiotherapy-induced ovarian follicular loss: impact on insulin-like growth factor 1","volume":"154","author":"Mahran","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.114.126136","article-title":"Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries","volume":"92","author":"Piasecka-Srader","year":"2015","journal-title":"Biol Reprod"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib93","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10549-020-05933-7","article-title":"Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer","volume":"185","author":"Goldfarb","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib94","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/humupd\/dmz039","article-title":"The role of microRNAs in ovarian function and the transition toward novel therapeutic strategies in fertility preservation: from bench to future clinical application","volume":"26","author":"Alexandri","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-45642-w","article-title":"MicroRNA profiling and identification of let-7a as a target to prevent chemotherapy-induced primordial follicles apoptosis in mouse ovaries","volume":"9","author":"Alexandri","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib96","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/molehr\/gaaa068","article-title":"Extracellular vesicles miRNA-21: a potential therapeutic tool in premature ovarian dysfunction","volume":"26","author":"Thabet","year":"2020","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib97","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-017-0641-z","article-title":"Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis","volume":"8","author":"Fu","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib98","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/stem.3204","article-title":"Exosomal miRNA-17-5p derived from human umbilical cord mesenchymal stem cells improves ovarian function in premature ovarian insufficiency by regulating SIRT7","volume":"38","author":"Ding","year":"2020","journal-title":"Stem Cell"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib99","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41374-019-0321-y","article-title":"Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN","volume":"100","author":"Yang","year":"2020","journal-title":"Lab Invest"},{"key":"10.1016\/j.bpobgyn.2025.102603_bib100","article-title":"MicroRNA-144-3p protects against chemotherapy-induced apoptosis of ovarian granulosa cells and activation of primordial follicles by targeting MAP3K9","volume":"28","author":"Liu","year":"2023","journal-title":"Eur J Med Res"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425000276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425000276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:39:49Z","timestamp":1762547989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693425000276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":100,"alternative-id":["S1521693425000276"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102603","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can we really protect the ovary from chemotherapy damage?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102603"}}